P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Ndhlovu, L.
- Beteiligte Personen und Organisationen
-
Sinclair, E.
Epling, L.
Tan, QX
Ho, T.
Jha, AR
Levy, JA
Nixon, DF
Barbour, JD
Hecht, FM
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P239
- URN
-
urn:nbn:de:1111-201608079497
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ndhlovu, L.
- Sinclair, E.
- Epling, L.
- Tan, QX
- Ho, T.
- Jha, AR
- Levy, JA
- Nixon, DF
- Barbour, JD
- Hecht, FM
- SpringerLink (Online service)
Ähnliche Objekte (12)
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
A search for allorestricted T-cells
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
A search for allorestricted T-cells
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?